Medartis Holding AG (MDRSF) Research

Medartis Holding AG is a Switzerland-based medical technology firm, founded in 1997 and headquartered in Basel. The company specializes in the global creation, production, and distribution of advanced implant solutions. These sophisticated medical devices are engineered to support the surgical repair and stabilization of bone fractures, specifically targeting injuries in both upper and lower limbs, as well as intricate cranio-maxillofacial surgeries. Operating under its prominent APTUS and MODUS brands, Medartis provides a comprehensive array of osteosynthesis instruments. These specialized tools and implants are designed for a wide spectrum of anatomical applications, including procedures involving the hand, wrist, elbow, shoulder, foot, and ankle, alongside the mandible, midface, orthognathic, and cranial regions. Medartis serves a diverse international client base, including surgeons, hospitals, medical centers, and various group purchasing organizations.

Market snapshot

Symbol
MDRSF
Price
$115
Day change
0.00%
Market cap
$922.3M
P/E ratio
110.34x
52-week range
66.68-115
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months

Peer companies

  • Biotage AB (publ) (BITGF)
  • CompuGroup Medical SE & Co. KGaA (CMPUY)
  • CompuGroup Medical SE & Co. KGaA (CMPVF)
  • Drägerwerk AG & Co. KGaA (DGWPF)
  • Drägerwerk AG & Co. KGaA (DWRKF)
  • Karo Pharma AB (publ) (KARBF)
  • Kaken Pharmaceutical Co., Ltd. (KKPCF)
  • Luye Pharma Group Ltd. (LYPHF)

Open Medartis Holding AG (MDRSF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.